Maryland State Retirement & Pension System Purchases 2,225 Shares of Cigna Group $CI

Maryland State Retirement & Pension System raised its position in Cigna Group (NYSE:CI – Free Report) by 15.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,203 shares of the health services provider’s stock after buying an additional 2,225 shares during the period. Maryland State Retirement & Pension System’s holdings in Cigna Group were worth $4,404,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Illinois Municipal Retirement Fund raised its position in Cigna Group by 0.6% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 14,588 shares of the health services provider’s stock valued at $3,965,000 after purchasing an additional 86 shares during the last quarter. Cornerstone Wealth Management LLC increased its stake in shares of Cigna Group by 3.7% in the third quarter. Cornerstone Wealth Management LLC now owns 1,801 shares of the health services provider’s stock valued at $490,000 after buying an additional 65 shares in the last quarter. Alexander Randolph Advisory Inc. increased its stake in shares of Cigna Group by 4.4% in the third quarter. Alexander Randolph Advisory Inc. now owns 8,557 shares of the health services provider’s stock valued at $2,326,000 after buying an additional 363 shares in the last quarter. 71 West Capital Partners increased its stake in shares of Cigna Group by 6.2% in the third quarter. 71 West Capital Partners now owns 2,103 shares of the health services provider’s stock valued at $572,000 after buying an additional 123 shares in the last quarter. Finally, AlphaCore Capital LLC raised its holdings in shares of Cigna Group by 25.9% in the third quarter. AlphaCore Capital LLC now owns 7,916 shares of the health services provider’s stock valued at $2,152,000 after buying an additional 1,626 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

CI has been the topic of several research reports. Sanford C. Bernstein upped their price target on shares of Cigna Group from $387.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday. Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price objective for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Robert W. Baird set a $362.00 target price on shares of Cigna Group in a research note on Friday, July 31st. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Sunday, November 8th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $337.00 target price on shares of Cigna Group in a research report on Thursday, October 1st. Fourteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $336.90.

Read Our Latest Research Report on Cigna Group

Key Cigna Group News

These are some of the CI news items that stood out recently:

  • Positive Sentiment: Coverage points to a raised earnings outlook following a strong third quarter, which could improve expectations for future results. CIBC also included Cigna in a defensive stock-pick list. Cigna earnings outlook CIBC defensive stock-pick list
  • Neutral Sentiment: Analyst sentiment remains moderately bullish overall, although coverage notes Cigna has lagged industry peers and the broader market. Analyst sentiment overview
  • Negative Sentiment: Piper Sandler trimmed its target from $370 to $360, though it retained an overweight rating. Separately, CIBC cited the possibility of a tougher regulatory environment after the election as a risk for corporate America. Piper Sandler target revision CIBC election-related context

Cigna Group Price Performance

Shares of CI stock opened at $296.79 on Monday. The firm has a market cap of $78.20 billion, a price-to-earnings ratio of 13.10, a PEG ratio of 1.11 and a beta of 0.25. Cigna Group has a 12 month low of $257.85 and a 12 month high of $318.05. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock has a 50-day moving average price of $287.53 and a 200 day moving average price of $282.70.

Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The firm had revenue of $73.79 billion for the quarter, compared to analysts’ expectations of $72.64 billion. During the same period last year, the firm earned $7.83 earnings per share. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. Research analysts expect that Cigna Group will post 30.71 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s dividend payout ratio (DPR) is currently 27.54%.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole Jones sold 2,677 shares of Cigna Group stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Cigna Group Profile

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.